cinpropazide

potent vasodilator exerting principal action on intramyocardial circulation increasing the blood flow of the coronary vessels & of the endocardic microcirculation; structure

Also Known As:

1-(3',4',5'-trimethoxycinnamoyl)-4-(N-isopropylaminocarbonylmethyl)piperazine maleate; MD 68111

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - cinpropazide: 1

Related Diseases

1.	Ischemia 09/01/1985 - "It is concluded that cinpropazide attenuates myocardial acidosis during ischemia." 09/01/1985 - "Restoration of myocardial [H+] 60 min after the injection of cinpropazide was 75.3%, and that of saline solution was 29.5%, indicating that cinpropazide restored the myocardial [H+] by 45.8% during ischemia. "
2.	Acidosis 09/01/1985 - "Effect of cinpropazide on ischemic myocardial acidosis in dogs." 09/01/1985 - "It is concluded that cinpropazide attenuates myocardial acidosis during ischemia."

Related Drugs and Biologics

1.	Saline Solution